Condensed Consolidated Statements of Comprehensive Profit (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2024 |
Sep. 30, 2025 |
Sep. 30, 2024 |
|
| Income | ||||
| Mark to Market Gain/(Loss) | $ 0 | $ (127) | $ 0 | $ (835) |
| Realized Gain – Private Investments | 11,663 | |||
| Dividend Income | 0 | 0 | 0 | 75,687 |
| Gain (loss) from operations | 0 | (127) | 0 | 86,515 |
| Operating expenses: | ||||
| Compensation – stock options | 16,501 | 8,341 | 49,502 | 104,178 |
| Professional fees | 1,657 | 7,124 | 4,913 | 10,880 |
| State and local taxes | 4,850 | 6,352 | 14,979 | 16,052 |
| General and administrative expenses | 1,395 | 492 | (4,465) | 2,134 |
| Total operating expenses | 24,403 | 22,309 | 64,929 | 133,244 |
| Loss from operations | (24,403) | (22,436) | (64,929) | (46,729) |
| Other expense: | ||||
| Interest expense | 61,776 | 54,713 | 179,244 | 168,661 |
| Net operating loss | (86,179) | (77,149) | (244,173) | (215,390) |
| COMPREHENSIVE LOSS, NET OF TAX | ||||
| Net operating gain (loss) | (86,179) | (77,149) | (244,173) | (215,390) |
| Unrealized holding gain (loss) arising during the period | (33,059) | |||
| Comprehensive profit | $ (86,179) | $ (77,149) | $ (244,173) | $ (248,449) |
| Basic gain (loss) per share | ||||
| Net operating loss per share (in dollars per share) | $ (0.03) | $ (0.03) | $ (0.09) | $ (0.08) |
| Net comprehensive profit (loss) per share (in dollars per share) | $ (0.03) | $ (0.03) | $ (0.09) | $ (0.09) |
| Weighted average shares outstanding (in shares) | 2,726,955 | 2,726,955 | 2,726,955 | 2,726,955 |
| X | ||||||||||
- Definition The amount of comprehensive income or loss for the period per each share. No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses (income) of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. No definition available.
|
| X | ||||||||||
- Definition A fee, net of any income, charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of realized gain (loss) on investment in debt and equity securities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment in debt and equity securities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense for debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|